Sirtuin-1 Regulates Organismal Growth by Altering Feeding Behavior

Total Page:16

File Type:pdf, Size:1020Kb

Sirtuin-1 Regulates Organismal Growth by Altering Feeding Behavior © 2020. Published by The Company of Biologists Ltd | Journal of Cell Science (2020) 133, jcs239467. doi:10.1242/jcs.239467 RESEARCH ARTICLE Sirtuin-1 regulates organismal growth by altering feeding behavior and intestinal morphology in planarians Benjamin Ziman1,2, Peter Karabinis1,2, Paul Barghouth1,2 and Néstor J. Oviedo1,2,3,* ABSTRACT metabolism at the systemic level is challenging due to the complex Nutrient availability upon feeding leads to an increase in body size in regulatory mechanisms involved, and the fact that downregulation the planarian Schmidtea mediterranea. However, it remains unclear of sirtuin often results in developmental defects and decreased how food consumption integrates with cell division at the organismal lifespan (Dang, 2014; Lemieux et al., 2005; Li et al., 2007; level. Here, we show that the NAD-dependent protein deacetylases McBurney et al., 2003; Mostoslavsky et al., 2006; Vakhrusheva sirtuins are evolutionarily conserved in planarians, and specifically et al., 2008). Despite widespread interest in understanding the demonstrate that the homolog of human sirtuin-1 (SIRT1) (encoded links between metabolism, homeostasis and disease, the by Smed-Sirt-1), regulates organismal growth by impairing both mechanisms by which sirtuin regulates body growth and animal feeding behavior and intestinal morphology. Disruption of Smed-Sirt- behavior are mostly unknown. 1 with RNAi or pharmacological inhibition of Sirtuin-1 leads to reduced To gain insight into sirtuin function in the regulation of body animal growth. Conversely, enhancement of Sirtuin-1 activity with homeostasis, we focus on the planarian flatworm Schmidtea resveratrol accelerates growth. Differences in growth rates were mediterranea, which is an emerging model organism that has the associated with changes in the amount of time taken to locate food unique capability of responding to nutrient availability by either and overall food consumption. Furthermore, Smed-Sirt-1(RNAi) increasing or decreasing body size. Changes in planarian size are animals displayed reduced cell death and increased stem cell noticeable within a few weeks and result from variations in cell proliferation accompanied by impaired expression of intestinal number across the body rather than changes in cellular size (Baguna lineage progenitors and reduced branching of the gut. Taken and Romero, 1981; Oviedo et al., 2003; Takeda et al., 2009; together, our findings indicate that Sirtuin-1 is a crucial metabolic Thommen et al., 2019). Consequently, smaller animals will contain hub capable of controlling animal behavior, tissue renewal and fewer cells than their larger counterparts, but their proportions are morphogenesis of the adult intestine. maintained despite differences in body size. Independently of their size or metabolic input, planarians are constantly renewing KEY WORDS: Sirtuin, Planarians, Stem cells, Neoblasts, differentiated tissues, fueled by a large pool of adult stem cells Metabolism, Growth called neoblasts. The neoblast is the only cell type with capacity to divide during tissue renewal and in response to injury repair INTRODUCTION (Wagner et al., 2011; Zeng et al., 2018). Therefore, the maintenance Sirtuins are a group of highly conserved protein deacetylases that of body proportionality in planarians results from finely balanced require oxidized nicotinamide adenine dinucleotide (NAD+)asa regulation of cell division and cell death that is greatly influenced by cofactor for their enzymatic function. The ratio of NAD+ to reduced the availability of nutrients. Recent research has revealed nicotinamide dinucleotide (NADH) in response to the nutrient state evolutionary conservation in planarians of signaling pathways of cells links sirtuin function to metabolism. Sirtuin proteins are associated with metabolism (such as TOR and insulin signaling) cellular sensors that function in response to metabolic inputs and (Gonzalez-Estevez et al., 2012; Miller and Newmark, 2012; Peiris that regulate stem cells, growth factor signaling, and food intake et al., 2012; Roberts-Galbraith et al., 2016), but it remains unknown (Arul Nambi Rajan et al., 2018; Calvanese et al., 2010; Dietrich whether sirtuins influence the cellular flux that occurs in response to et al., 2010; Fujitsuka et al., 2016; Hisahara et al., 2008; Igarashi tissue turnover and nutrients in planarians. and Guarente, 2016; Li et al., 2007; Martins et al., 2012; Ou et al., Our results show that sirtuins are molecularly conserved in 2011; Prozorovski et al., 2008; Saunders et al., 2010; Velasquez planarians. We discovered that homologs for six of the seven et al., 2011). Recent evidence implicates sirtuins in a myriad of mammalian sirtuins are present in the S. mediterranea genome human conditions including obesity related disease, aging and (Smed-Sirt-1–6). This is intriguing because evolutionarily related cancer, but the mechanistic roles that sirtuins play in these invertebrate organisms such as Caenorhabditis elegans and conditions remain elusive (DeBerardinis et al., 2008; Houtkooper Drosophila melanogaster possess fewer sirtuin orthologs than et al., 2012; Kurylowicz, 2016). Studying the role of sirtuins in mammals and planarians (Frye, 2000; Vassilopoulos et al., 2011). Furthermore, we found that it is possible to modulate sirtuin 1Department of Molecular and Cell Biology, University of California, Merced, function in planarians using RNAi and treatment with CA 95343, USA. 2Quantitative and Systems Biology Graduate Program, University pharmacological compounds used in vertebrate experimental of California, Merced, CA 95343, USA. 3Health Sciences Research Institute, models and humans (Bhatt et al., 2012; Brasnyó et al., 2011; University of California, Merced, CA 95343, USA. Knop et al., 2013; Liu et al., 2014; Nguyen et al., 2009). Disrupting *Author for correspondence ([email protected]) Sirtuin-1 in planarians led to reduced body size, an unexpected increase in stem cell division and a reduction in levels of cell death. N.J.O., 0000-0002-0213-9781 These effects were accompanied by a reduced branching of the gut. Handling Editor: Maria Carmo-Fonseca Our analysis revealed that Sirtuin-1 plays an integral role in feeding Received 20 September 2019; Accepted 19 March 2020 behavior, regulating not only the length of time taken to locate food Journal of Cell Science 1 RESEARCH ARTICLE Journal of Cell Science (2020) 133, jcs239467. doi:10.1242/jcs.239467 and begin feeding but also overall food consumption. Taken with double-stranded RNA (dsRNA) over ten days, and animals together, our findings provide evidence for regulation of cellular were fixed 15 days after the first injection (Fig. 1A). We confirmed turnover by Sirtuin-1, and introduce planarians as a tractable that the protocol was effective in knocking down the gene experimental model to investigate regulation of metabolic inputs expression for two weeks without noticeable abnormalities and cellular behavior in the adult body. (Fig. S2A). Sirtuin function is linked to regulation of metabolism; therefore, RESULTS we analyzed how nutrient availability impacted animal size over Sirtuins are evolutionarily conserved, and Sirtuin-1 is time. First, we prolonged the RNAi protocol for about one month in required for organismal growth in the planarian the absence of nutrients and evaluated the effects on the reduction in S. mediterranea animal size (Fig. S2B). These experiments demonstrated that Sirtuins are a group of NAD+-regulated deacetylase enzymes that disturbing Smed-Sirt-1–6 function does not affect the reduction in are highly conserved from yeast to humans (Frye, 2000; Satoh et al., the overall size of planarians, termed ‘degrowth’ (Fig. S2C). 2011). In the genome of S. mediterranea (Rozanski et al., 2019), we Second, animals subjected to RNAi were exposed to nutrients, and identified homologs for six of the seven human sirtuins, Smed-Sirt- their growth was evaluated for almost two months. This protocol 1–6 (Fig. S1A). Although most of the S. mediterranea sirtuins alternated six feedings with RNAi of the individual Smed-Sirt-1–6 appear evolutionarily conserved, the protein encoded by Smed-Sirt- transcripts and was effective in reducing expression for 1 showed the highest molecular similarity to its counterparts in approximately two months (Fig. 1B; Fig. S2D). The analysis humans and other species, sharing 60% amino acid sequence shows that control and Smed-Sirt-2–6(RNAi) animals increased in identity with human sirtuin-1 (also known as SIRT1) in the size at a similar rate, whereas animals subjected to Smed-Sirt- SIRTUIN domain (Fig. S1A–C). 1(RNAi) displayed a 30% reduction in growth (Fig. 1C,D; Fig. S2E). To functionally characterize the role of sirtuins in planarians, Additionally, Smed-Sirt-1 expression was increased upon feeding, we performed RNAi of the individual Smed-Sirt-1–6 transcripts. suggesting a potential role in planarian metabolism (Fig. S2F). We developed an RNAi strategy based on multiple microinjections Based on these observations, we concluded that Smed-Sirt-1 is Fig. 1. Smed-Sirt-1 regulates planarian growth. (A) RNAi treatment schedule showing timing of microinjections with dsRNA of Smed-Sirt-1. Black bars represent injections with Smed-Sirt-1 dsRNA and the red bar represents the time of fixation. (B) RNAi growth schedule, which combined Smed-Sirt-1 dsRNA microinjections (black bars) with liver feeding (green bars). The red bar represents time of fixation. (C) Changes in animal area over the RNAi growth schedule. Changes
Recommended publications
  • Effect of a Caloric Restriction Based On
    UNIVERSIDAD AUTÓNOMA DE MADRID FACULTAD DE CIENCIAS DEPARTAMENTO DE BIOLOGÍA DOCTORAL THESIS Biology PhD “Effect of a caloric restriction based on the Mediterranean diet and intake of traditional Mediterranean foods on the expression of microRNAs regulating molecular processes associated with aging” INSTITUTO MADRILEÑO DE ESTUDIOS AVANZADOS EN ALIMENTACIÓN (IMDEA FOOD INSTITUTE) VÍCTOR MICÓ MORENO Madrid, 2018 UNIVERSIDAD AUTÓNOMA DE MADRID FACULTAD DE CIENCIAS DEPARTAMENTO DE BIOLOGÍA DOCTORAL THESIS Biology PhD “Effect of a caloric restriction based on the Mediterranean diet and intake of traditional Mediterranean foods on the expression of microRNAs regulating molecular processes associated with aging” INSTITUTO MADRILEÑO DE ESTUDIOS AVANZADOS EN ALIMENTACIÓN (IMDEA FOOD INSTITUTE) Memoria presentada por: Víctor Micó Moreno Para optar al grado de: DOCTOR EN BIOLOGÍA Doña Lidia Ángeles Daimiel Ruíz, Doctora en Biología Celular y Genética por la Universidad Autónoma de Madrid, investigadora del Instituto IMDEA Alimentación, informa favorablemente la solicitud de autorización de defensa de la tesis doctoral con el Título: “Effect of a caloric restriction based on the Mediterranean diet and intake of traditional Mediterranean foods on the expression of microRNAs regulating molecular processes associated with aging”, presentada por Don Víctor Micó Moreno para optar al grado de Doctor en Biología. Este trabajo ha sido realizado en el Instituto Madrileño de Estudios Avanzados en Alimentación (IMDEA Alimentación) bajo su dirección, y cumple satisfactoriamente las condiciones requeridas por el Departamento de Biología de la Universidad Autónoma de Madrid para optar al Título de Doctor. Ha actuado como tutor académico, y presenta su conformidad el Dr. Carlos Francisco Sentís Castaño, vicedecano de Personal Docente e Investigador y profesor titular del Departamento de Biología de la Facultad de Ciencias de la Universidad Autónoma de Madrid.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Compartmentation of NAD+-Dependent Signalling ⇑ ⇑ Friedrich Koch-Nolte A, , Stefan Fischer B, Friedrich Haag A, Mathias Ziegler B
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector FEBS Letters 585 (2011) 1651–1656 journal homepage: www.FEBSLetters.org Review Compartmentation of NAD+-dependent signalling ⇑ ⇑ Friedrich Koch-Nolte a, , Stefan Fischer b, Friedrich Haag a, Mathias Ziegler b, a Institute of Immunology, University Medical Center, Martinistr. 52, 20246 Hamburg, Germany b Department of Molecular Biology, University of Bergen, Thormøhlensgate 55, 5008 Bergen, Norway article info abstract Article history: NAD+ plays central roles in energy metabolism as redox carrier. Recent research has identified Received 25 February 2011 important signalling functions of NAD+ that involve its consumption. Although NAD+ is synthesized Revised 21 March 2011 mainly in the cytosol, nucleus and mitochondria, it has been detected also in vesicular and extracel- Accepted 21 March 2011 lular compartments. Three protein families that consume NAD+ in signalling reactions have been Available online 31 March 2011 characterized on a molecular level: ADP-ribosyltransferases (ARTs), Sirtuins (SIRTs), and NAD+ glyco- Edited by Sergio Papa, Gianfranco Gilardi hydrolases (NADases). Members of these families serve important regulatory functions in various and Wilhelm Just cellular compartments, e.g., by linking the cellular energy state to gene expression in the nucleus, by regulating nitrogen metabolism in mitochondria, and by sensing tissue damage in the extracel- + Keywords: lular compartment. Distinct NAD pools may be crucial for these processes. Here, we review the cur- + NAD+ rent knowledge about the compartmentation and biochemistry of NAD -converting enzymes that + ADP-ribosyltransferase control NAD signalling. Sirtuins Ó 2011 Federation of European Biochemical Societies.
    [Show full text]
  • Metabolic Regulation of Epigenetic Modifications and Cell
    cancers Review Metabolic Regulation of Epigenetic Modifications and Cell Differentiation in Cancer Pasquale Saggese 1, Assunta Sellitto 2 , Cesar A. Martinez 1, Giorgio Giurato 2 , Giovanni Nassa 2 , Francesca Rizzo 2 , Roberta Tarallo 2 and Claudio Scafoglio 1,* 1 Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA; [email protected] (P.S.); [email protected] (C.A.M.) 2 Laboratory of Molecular Medicine and Genomics, Department of Medicine, Surgery and Dentistry ‘Scuola Medica Salernitana’, University of Salerno, 84081 Baronissi (SA), Italy; [email protected] (A.S.); [email protected] (G.G.); [email protected] (G.N.); [email protected] (F.R.); [email protected] (R.T.) * Correspondence: [email protected]; Tel.: +1-310-825-9577 Received: 20 October 2020; Accepted: 11 December 2020; Published: 16 December 2020 Simple Summary: Cancer cells change their metabolism to support a chaotic and uncontrolled growth. In addition to meeting the metabolic needs of the cell, these changes in metabolism also affect the patterns of gene activation, changing the identity of cancer cells. As a consequence, cancer cells become more aggressive and more resistant to treatments. In this article, we present a review of the literature on the interactions between metabolism and cell identity, and we explore the mechanisms by which metabolic changes affect gene regulation. This is important because recent therapies under active investigation target both metabolism and gene regulation. The interactions of these new therapies with existing chemotherapies are not known and need to be investigated.
    [Show full text]
  • Global Profiling of Metabolic Adaptation to Hypoxic Stress in Human Glioblastoma Cells
    Global profiling of metabolic adaptation to hypoxic stress in human glioblastoma cells. Kucharzewska, Paulina; Christianson, Helena; Belting, Mattias Published in: PLoS ONE DOI: 10.1371/journal.pone.0116740 2015 Link to publication Citation for published version (APA): Kucharzewska, P., Christianson, H., & Belting, M. (2015). Global profiling of metabolic adaptation to hypoxic stress in human glioblastoma cells. PLoS ONE, 10(1), [e0116740]. https://doi.org/10.1371/journal.pone.0116740 Total number of authors: 3 General rights Unless other specific re-use rights are stated the following general rights apply: Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal Read more about Creative commons licenses: https://creativecommons.org/licenses/ Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. LUND UNIVERSITY PO Box 117 221 00 Lund +46 46-222 00 00 Download date: 07. Oct. 2021 RESEARCH ARTICLE Global Profiling of Metabolic Adaptation to Hypoxic Stress in Human Glioblastoma Cells Paulina Kucharzewska1, Helena C.
    [Show full text]
  • Epigenetic Regulation in B-Cell Maturation and Its Dysregulation in Autoimmunity
    OPEN Cellular and Molecular Immunology (2018) 15, 676–684 www.nature.com/cmi REVIEW Epigenetic regulation in B-cell maturation and its dysregulation in autoimmunity Haijing Wu1, Yaxiong Deng1, Yu Feng1, Di Long1, Kongyang Ma2, Xiaohui Wang2, Ming Zhao1, Liwei Lu2 and Qianjin Lu1 B cells have a critical role in the initiation and acceleration of autoimmune diseases, especially those mediated by autoantibodies. In the peripheral lymphoid system, mature B cells are activated by self or/and foreign antigens and signals from helper T cells for differentiating into either memory B cells or antibody-producing plasma cells. Accumulating evidence has shown that epigenetic regulations modulate somatic hypermutation and class switch DNA recombination during B-cell activation and differentiation. Any abnormalities in these complex regulatory processes may contribute to aberrant antibody production, resulting in autoimmune pathogenesis such as systemic lupus erythematosus. Newly generated knowledge from advanced modern technologies such as next-generation sequencing, single-cell sequencing and DNA methylation sequencing has enabled us to better understand B-cell biology and its role in autoimmune development. Thus this review aims to summarize current research progress in epigenetic modifications contributing to B-cell activation and differentiation, especially under autoimmune conditions such as lupus, rheumatoid arthritis and type 1 diabetes. Cellular and Molecular Immunology advance online publication, 29 January 2018; doi:10.1038/cmi.2017.133 Keywords:
    [Show full text]
  • Activation of the AMPK/Sirt1 Pathway by a Leucine
    METABOLISM CLINICAL AND EXPERIMENTAL 65 (2016) 1679– 1691 Available online at www.sciencedirect.com Metabolism www.metabolismjournal.com Activation of the AMPK/Sirt1 pathway by a leucine–metformin combination increases insulin sensitivity in skeletal muscle, and stimulates glucose and lipid metabolism and increases life span in Caenorhabditis elegans Jheelam Banerjee⁎, Antje Bruckbauer, Michael B. Zemel NuSirt BioPharma Inc., 11020 Solway School Road, Knoxville, TN 37931, USA ARTICLE INFO ABSTRACT Article history: Background. We have previously shown leucine (Leu) to activate Sirt1 by lowering its KM for Received 28 January 2016 NAD+, thereby amplifying the effects of other sirtuin activators and improving insulin Accepted 29 June 2016 sensitivity. Metformin (Met) converges on this pathway both indirectly (via AMPK) and by direct activation of Sirt1, and we recently found Leu to synergize with Met to improve insulin Keywords: sensitivity and glycemic control while achieving ~80% dose-reduction in diet-induced obese AMPK mice. Accordingly, we sought here to define the mechanism of this interaction. Sirt1 Methods. Muscle cells C2C12 and liver cells HepG2 were used to test the effect of Met–Leu on Insulin sensitivity Sirt1 activation. Caenorhabditis elegans was used for glucose utilization and life span studies. Leucine Results. Leu (0.5 mmol/L) + Met (50–100 μmol/L) synergistically activated Sirt1 (p < 0.001) at + Metformin low (≤100 μmol/L) NAD levels while Met exerted no independent effect. This was associated with an increase in AMPK and ACC, phosphorylation, and increased fatty acid oxidation, which was prevented by AMPK or Sirt inhibition or silencing. Met–Leu also increased P-IRS1/IRS1 and P-AKT/AKT and in insulin-independent glucose disposal in myotubes (~50%, p < 0.002) evident within 30 min as well as a 60% reduction in insulin EC50.
    [Show full text]
  • Unexpected Side Effects of Everyday Medication Through Sirtuin1 Modulation
    223-232 9/1/08 16:06 Page 223 INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 21: 223-232, 2008 223 Aging and anti-aging: Unexpected side effects of everyday medication through sirtuin1 modulation NICOLE ENGEL2 and ULRICH MAHLKNECHT1,2 1Saarland University Medical Center, Department of Hematology/Oncology, José Carreras Center for Immunotherapy and Gene Therapy, D-66424 Homburg/Saar; 2Department of Hematology/Oncology, University of Heidelberg Medical Center, Im Neuenheimer Feld 410, D-69120 Heidelberg, Germany Received August 28, 2007; Accepted October 19, 2007 Abstract. The sirtuin 1 protein (SIRT1) is a member of the Introduction class III NAD+-dependent histone deacetylases, which are also referred to as the ‘sirtuins’. The sirtuins and silent Reversible DNA and protein modification, such as acetylation information regulator 1 (SIRT1) in particular, are known to and deacetylation, are involved in the regulation of tran- play a role in the response to DNA damage, metabolism, scriptional activity and influence protein enzymatic activity. longevity and carcinogenesis. SIRT1 regulates different Acetylation of histone N-terminal lysine residues is carried cellular processes such as proliferation, differentiation and out by histone acetyltransferases (HATs) and is associated apoptosis through deacetylation of important regulatory with increased transcriptional activity in eukaryotic cells proteins such as p53, FOXO3a and NFκB. A number of through chromatin relaxation and may be reversed by different modifiers of SIRT1 expression and activity have competing histone deacetylase (HDAC) enzymatic activities, been discovered and even food and cosmetic additives (e.g. which cause histone deacetylation and thus chromatin resveratrol and dihydrocoumarin) have been suggested to condensation and subsequently repression of gene expression either activate or inhibit the activity of human SIRT1.
    [Show full text]
  • Global Proteomic Detection of Native, Stable, Soluble Human Protein Complexes
    GLOBAL PROTEOMIC DETECTION OF NATIVE, STABLE, SOLUBLE HUMAN PROTEIN COMPLEXES by Pierre Claver Havugimana A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy Graduate Department of Molecular Genetics University of Toronto © Copyright by Pierre Claver Havugimana 2012 Global Proteomic Detection of Native, Stable, Soluble Human Protein Complexes Pierre Claver Havugimana Doctor of Philosophy Graduate Department of Molecular Genetics University of Toronto 2012 Abstract Protein complexes are critical to virtually every biological process performed by living organisms. The cellular “interactome”, or set of physical protein-protein interactions, is of particular interest, but no comprehensive study of human multi-protein complexes has yet been reported. In this Thesis, I describe the development of a novel high-throughput profiling method, which I term Fractionomic Profiling-Mass Spectrometry (or FP-MS), in which biochemical fractionation using non-denaturing high performance liquid chromatography (HPLC), as an alternative to affinity purification (e.g. TAP tagging) or immuno-precipitation, is coupled with tandem mass spectrometry-based protein identification for the global detection of stably- associated protein complexes in mammalian cells or tissues. Using a cell culture model system, I document proof-of-principle experiments confirming the suitability of this method for monitoring large numbers of soluble, stable protein complexes from either crude protein extracts or enriched sub-cellular compartments. Next, I document how, using orthogonal functional genomics information generated in collaboration with computational biology groups as filters, we applied FP-MS co-fractionation profiling to construct a high-quality map of 622 predicted unique soluble human protein complexes that could be biochemically enriched from HeLa and HEK293 nuclear and cytoplasmic extracts.
    [Show full text]
  • Resveratrol and Vascular Function
    International Journal of Molecular Sciences Review Resveratrol and Vascular Function Huige Li 1,* , Ning Xia 1, Solveig Hasselwander 1 and Andreas Daiber 2,* 1 Department of Pharmacology, Johannes Gutenberg University Medical Center, 55131 Mainz, Germany; [email protected] (N.X.); [email protected] (S.H.) 2 Center for Cardiology, Cardiology I - Laboratory of Molecular Cardiology, Johannes Gutenberg University Medical Center, 55131 Mainz, Germany * Correspondence: [email protected] (H.L.); [email protected] (A.D.) Received: 25 March 2019; Accepted: 24 April 2019; Published: 30 April 2019 Abstract: Resveratrol increases the production of nitric oxide (NO) in endothelial cells by upregulating the expression of endothelial NO synthase (eNOS), stimulating eNOS enzymatic activity, and preventing eNOS uncoupling. At the same time, resveratrol inhibits the synthesis of endothelin-1 and reduces oxidative stress in both endothelial cells and smooth muscle cells. Pathological stimuli-induced smooth muscle cell proliferation, vascular remodeling, and arterial stiffness can be ameliorated by resveratrol as well. In addition, resveratrol also modulates immune cell function, inhibition of immune cell infiltration into the vascular wall, and improves the function of perivascular adipose tissue. All these mechanisms contribute to the protective effects of resveratrol on vascular function and blood pressure in vivo. Sirtuin 1, AMP-activated protein kinase, and estrogen receptors represent the major molecules mediating the vascular effects of resveratrol. Keywords: resveratrol; endothelium; endothelial nitic oxide synthase; sirtuin 1; cardiovascular disease; vascular function 1. Resveratrol and its Molecular Targets The polyphenolic phytoalexin 3,5,40-trihydroxy-trans-stilbene, better known under its trivial name resveratrol, can be found in numerous plants, such as white hellebore (Veratrum grandiflorum), mulberry (Morus rubra), peanut (Archis hypogaea), and grapes (Vitis vinifera)[1–3].
    [Show full text]
  • Metabolism Impacts on Proteostasis and Aging
    Cell Death & Differentiation (2021) 28:505–521 https://doi.org/10.1038/s41418-020-00682-y REVIEW ARTICLE Build-UPS and break-downs: metabolism impacts on proteostasis and aging 1 1 1,2 Franziska Ottens ● André Franz ● Thorsten Hoppe Received: 4 September 2020 / Revised: 9 November 2020 / Accepted: 10 November 2020 / Published online: 4 January 2021 © The Author(s) 2021, corrected publication 2021 Abstract Perturbation of metabolism elicits cellular stress which profoundly modulates the cellular proteome and thus protein homeostasis (proteostasis). Consequently, changes in the cellular proteome due to metabolic shift require adaptive mechanisms by molecular protein quality control. The mechanisms vitally controlling proteostasis embrace the entire life cycle of a protein involving translational control at the ribosome, chaperone-assisted native folding, and subcellular sorting as well as proteolysis by the proteasome or autophagy. While metabolic imbalance and proteostasis decline have been recognized as hallmarks of aging and age-associated diseases, both processes are largely considered independently. Here, we delineate how proteome stability is governed by insulin/IGF1 signaling (IIS), mechanistic target of Rapamycin (TOR), 5′ 1234567890();,: 1234567890();,: adenosine monophosphate-activated protein kinase (AMPK), and NAD-dependent deacetylases (Sir2-like proteins known as sirtuins). This comprehensive overview is emphasizing the regulatory interconnection between central metabolic pathways and proteostasis, indicating the relevance of shared signaling nodes as targets for future therapeutic interventions. Facts Open questions ● Metabolic imbalance and proteostasis decline have been ● Common signaling nodes and shared mechanisms of recognized as hallmarks of aging and age-associated proteostasis networks and metabolism remain to be diseases, both processes are largely considered identified.
    [Show full text]
  • Calmodulin-Dependent Protein Kinase Kinase Β Phosphorylation of Sirtuin 1 in Endothelium Is Atheroprotective
    Ca2+/calmodulin-dependent protein kinase kinase β phosphorylation of Sirtuin 1 in endothelium is atheroprotective Liang Wena,b, Zhen Chenb, Fan Zhangc, Xiaopei Cuib, Wei Sunb, Greg G. Gearyd, Yinsheng Wangc, David A. Johnsonb, Yi Zhua,1, Shu Chiene,1, and John Y.-J. Shyyb,f,1 aDepartment of Physiology and Pathophysiology, Peking University Health Sciences Center, Beijing 100191, China; bDivision of Biomedical Sciences and cDepartment of Chemistry, University of California, Riverside, CA 92521; dDepartment of Kinesiology and Health Sciences, California State University, San Bernardino, CA 92407; and Departments of eBioengineering and fMedicine, University of California, San Diego, La Jolla, CA 92093 Contributed by Shu Chien, May 16, 2013 (sent for review March 3, 2013) Atheroprotective flow exerts antioxidative and anti-inflammatory SIRT1, there could be a flow-responsive cytoplasmic kinase that effects on vascular endothelial cells (ECs), in part through the phosphorylates SIRT1 to enhance its activity. induction of Sirtuin 1 (SIRT1), a class III histone deacetylase. The role Like SIRT1, AMP-activated protein kinase (AMPK) functions of Ca2+/calmodulin-dependent protein kinase kinase (CaMKK)β in as a master regulator in stress response and energy homeostasis in flow induction of SIRT1 both in vitro and in vivo was investigated. eukaryotic cells. SIRT1 and AMPK are coregulated by caloric Pulsatile shear stress mimicking atheroprotective flow increased restriction, resveratrol, and exercise (15, 16), which coordinately the level of SIRT1 in cultured ECs by enhancing its stability, and this deacetylate and phosphorylate a common set of molecular targets effect was abolished by inhibition or knockdown of CaMKKβ.Flow- such as PGC1α (17).
    [Show full text]